Jiaze An

1.5k total citations
37 papers, 1.1k citations indexed

About

Jiaze An is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jiaze An has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Jiaze An's work include Nanoplatforms for cancer theranostics (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Mitochondrial Function and Pathology (6 papers). Jiaze An is often cited by papers focused on Nanoplatforms for cancer theranostics (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Mitochondrial Function and Pathology (6 papers). Jiaze An collaborates with scholars based in China and United States. Jiaze An's co-authors include Jinliang Xing, Qichao Huang, Xu Guo, Haiyan Cao, Lei Zhan, Bing-Rong Liu, Jibin Li, Tingting Ren, Jing Zhang and Yongzhan Nie and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Jiaze An

35 papers receiving 1.1k citations

Peers

Countries citing papers authored by Jiaze An

Since Specialization

Citations

This map shows the geographic impact of Jiaze An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaze An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaze An more than expected).

Fields of papers citing papers by Jiaze An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaze An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaze An. The network helps show where Jiaze An may publish in the future.

Co-authorship network of co-authors of Jiaze An

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaze An. A scholar is included among the top collaborators of Jiaze An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaze An. Jiaze An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Characteristics and Prognosis of Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study Based on Population Data 2024 ·Digestive Diseases and Sciences ·(unknown), (unknown), Jiaze An	4
2	Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Peng Li, Jing Qin, (unknown), Changhong Shi, Jiaze An	5
3	Near-infrared fluorescence imaging of hepatocellular carcinoma cells regulated by β-catenin signaling pathway 2023 ·Frontiers in Oncology ·Jian Song, Tingting Ren, (unknown), (unknown), Gang Wang, Yu Gan, (unknown), (unknown), Zheng Zhao, Jiaze An	0
4	The Application of [⁶⁸Ga]‐Labeled FAPI‐04 PET/CT for Targeting and Early Detection of Pancreatic Carcinoma in Patient‐Derived Orthotopic Xenograft Models 2022 ·Contrast Media & Molecular Imaging ·(unknown), Jiaze An, (unknown), Caiqin Zhang, Yong Zhao, (unknown), Changhong Shi, (unknown)	11
5	A computational framework to unify orthogonal information in DNA methylation and copy number aberrations in cell-free DNA for early cancer detection 2022 ·Briefings in Bioinformatics ·Qiang Wei, Jin Chao, Yang Wang, Shanshan Guo, Xu Guo, Xiaonan Liu, Jiaze An, Jinliang Xing, Bingshan Li	2
6	Mitochondrial fragmentation is crucial for c-Myc-driven hepatoblastoma-like liver tumors 2022 ·Molecular Therapy ·(unknown), (unknown), (unknown), Qing Yuan, Dan Wu, (unknown), (unknown), Shanshan Guo, Jianxun Wang, (unknown), Jinliang Xing, Jiaze An, Qichao Huang	20
7	Screening of an individualized treatment strategy for an advanced gallbladder cancer using patient-derived tumor xenograft and organoid models 2022 ·Frontiers in Oncology ·(unknown), Jiaze An, (unknown), Huihui Wang, Han Li, Meng Han, Caiqin Zhang, Yongheng Zhao, (unknown), Changhong Shi	8
8	Down-regulation of BMAL1 by MiR-494-3p Promotes Hepatocellular Carcinoma Growth and Metastasis by Increasing GPAM-mediated Lipid Biosynthesis 2022 ·International Journal of Biological Sciences ·Yi Yang, Tao Yang, (unknown), Hongxin Zhang, Peng Yuan, Gang Wang, Zheng Zhao, Jiaze An, (unknown), Jinliang Xing, Jibin Li	31
9	Lipocalin 2 may be a key factor regulating the chemosensitivity of pancreatic cancer to gemcitabine 2022 ·Biochemistry and Biophysics Reports ·He Zhang, Pengpeng Wu, (unknown), Caiqin Zhang, Yong Zhao, (unknown), Jiaze An, Changhong Shi	3
10	Genetic Variants in NPAS2 Gene and Clinical Outcomes of Resectable Non-Small-Cell Lung Cancer 2021 ·Future Oncology ·(unknown), Gang Wang, Qian Wang, Zheng Zhao, Lu Gan, (unknown), Yongxing Wang, Shanshan Guo, Jiaze An, Jian Zhang, Zhaohui Zhang, Feng Zhou	10
11	Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma 2019 ·Oncogene ·Jing Zhao, Yiran Hou, Chun Yin, Jing Hu, Tian Gao, Xiao‐Jun Huang, Xiaohong Zhang, Jinliang Xing, Jiaze An, Shaogui Wan, Jibin Li	38
12	Mitochondrial fission forms a positive feedback loop with cytosolic calcium signaling pathway to promote autophagy in hepatocellular carcinoma cells 2017 ·Cancer Letters ·Qichao Huang, Haiyan Cao, Lei Zhan, Xiacheng Sun, Gang Wang, Jibin Li, Xu Guo, Tingting Ren, Zhe Wang, (unknown), Bingrong Liu, Jiaze An, Jinliang Xing	56
13	Genetic variations of mitochondrial genome modify risk and prognosis of hepatocellular carcinoma patients 2017 ·Clinics and Research in Hepatology and Gastroenterology ·Cheng Chen, Yanna Ba, Deyang Li, Xiaohong Du, (unknown), Hai Yang, Jiaze An, Jinliang Xing, Hushan Yang, Guanglong Dong, Xu Guo	15
14	Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma 2016 ·Clinics and Research in Hepatology and Gastroenterology ·(unknown), Yibing Chen, Xu Guo, Feng Zhou, (unknown), Jinliang Xing, Jiaze An, Hongxin Zhang	13
15	Polymorphisms in Genes of Tricarboxylic Acid Cycle Key Enzymes Are Associated with Early Recurrence of Hepatocellular Carcinoma 2015 ·PLoS ONE ·Shaogui Wan, Yousheng Wu, Xingchun Zhou, Yibing Chen, Jiaze An, (unknown), Huiqing Zhang, Hushan Yang, Jinliang Xing	4
16	Neuroprotective effects of Asiaticoside 2014 ·Neural Regeneration Research ·Shui‐bing Liu, Jiaze An, (unknown), Le Yang, Zhen Tian, Ming Zhao	35
17	Low expression of CD112 is associated with poor overall survival in patients with hepatocellular carcinoma 2014 ·Human Pathology ·Xiao‐Jun Huang, Ping Qü, Yibing Chen, Xingchun Zhou, Yousheng Wu, Fange Liu, Dandan Wang, Jing Zhang, Jiaze An	11
18	A Genetic Variant in Primary miR-378 Is Associated with Risk and Prognosis of Hepatocellular Carcinoma in a Chinese Population 2014 ·PLoS ONE ·Jiaze An, Ji‐Bin Liu, Li Liu, Yao Liu, Yun Pan, Mingde Huang, Fuzhen Qi, Juan Wen, Kaipeng Xie, Hongxia Ma, Hongbing Shen, Zhibin Hu	21
19	Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization 2012 ·Carcinogenesis ·Han-Qiang Liu, Jiaze An, Juan Liu, Yefa Yang, Hongxin Zhang, (unknown), Jibin Li, Hushan Yang, Zhi‐Nan Chen, Jinliang Xing	30
20	A Meta-Analysis of Array-CGH Studies Implicates Antiviral Immunity Pathways in the Development of Hepatocellular Carcinoma 2011 ·PLoS ONE ·Xu Guo, (unknown), Xi Ma, Jiaze An, (unknown), Qichao Huang, Hushan Yang, Zhi‐Nan Chen, Jinliang Xing	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact